Neoglycyrol
CAS: 23013-84-5
Ref. 3D-YAA01384
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
- 3,9-Dihydroxy-1-methoxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one
- 3,9-Dihydroxy-1-methoxy-2-(3-methyl-but-2-enyl)-benzofuro[3,2-c][1]benzopyran-6-one
- 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-1-methoxy-2-(3-methyl-2-butenyl)-
- 6H-benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-1-methoxy-2-(3-methyl-2-buten-1-yl)-
- Glycyrol
Neoglycyrol is a compound that exhibits various characteristics and properties. It is derived from dimethyl fumarate and has been shown to scavenge superoxide radicals, which are harmful to cells. Neoglycyrol can form polymers in the presence of protons, making it useful for applications in materials science and drug delivery systems. Additionally, it has been found to possess saponin-like activity, which may have potential therapeutic effects.
In research studies, neoglycyrol has demonstrated its ability to act as a racemase inhibitor, preventing the conversion of one enantiomer to another. This property could be valuable in pharmaceutical development where chirality plays a crucial role.
Furthermore, neoglycyrol has shown interactions with other compounds such as felodipine and dimethyl sulfoxide (DMSO), suggesting its potential use in combination therapies or drug formulations. It also exhibits affinity towards fatty acids and potassium ions.
As a research chemical, neog
